Department of Oncology-Pathology
The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer.
Lars Holmgren on twitter
Lars Holmgren on twitter
Follow the chair of the department of Oncology-Pathology Lars Holmgren on twitter.
AI improves precision in breast cancer diagnosis
AI improves precision in breast cancer diagnosis
Johan Hartman with colleagues at Karolinska Institutet have developed an AI-based tool that improves the diagnosis of breast cancer tumours and the ability to predict the risk of recurrence. The greater diagnostic precision can lead to more personalised treatment for the large group of breast cancer patients with intermediate risk tumours. The results are published in the scientific journal Annals of Oncology.
New top publicaton from Lars Holmgren’s group
New top publicaton from Lars Holmgren’s group
Yuanyuan Zhang is the first author of an article i Cell Reports showing a specific protein complex being important for the formation of blood vessels. This can have implications for the formation of blood vessels in tumors and tumor growth.
Review article in The Lancet Diabetes & Endocrinology from Christofer Juhlin
Review article in The Lancet Diabetes & Endocrinology from Christofer Juhlin
Christofer Juhlin together with colleagues from KI, Uppsala University and Mayo Clinic (USA) has published a review article in The Lancet Diabetes & Endocrinology where they discuss genetics, pathology, radiology and clinical management of adrenal myelolipomas, a benign tumor.
Translational seed grants for researchers at OnkPat
Four researchers at OnkPat has received funding from Cancer Research KI. It is Arne Östman and Alexios Matikas who has received funding for the project ”High-content tissue profiling for discovery of novel vessel- and fibroblast-derived prognostic and predictive early breast cancer biomarkers.” and Hanna Eriksson and Maria Pernemalm who got the funding for the project ”Delineating the Systemic Landscape in Brain Metastatic Melanoma for Improve Cllinical Decision-Making.”
Publication in Lancet Oncology by Jonas Bergh
Publication in Lancet Oncology by Jonas Bergh
Jonas Bergh is co-author for an article in Lancet Oncology which has been published by The Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Jonas Bergh is also co-chair of the Steering Committee and member of the Writing Committe for EBCTCG.
New treatment method for breast cancer with less side effects
Thomas Hatschek, Associate Professor at the department of Oncology-Pathology together with colleagues has recently published an article in JAMA Oncology where they show that a new treatment for breast cancer with an antibody linked to a cytotoxic drug is as good as the previous combination, but with less side effects.
KI-Mayo Collaborative grant recipient
Arne Östman has received the KI-Mayo Collaborative grant for 2021 for his project ”Exploration of fibroblasts as biologically relevant biomarkers in breast benign disease”. The Mayo Clinic Cancer Center researcher is Derek Radisky.